Search
Displaying 1151–1160 of 1176 results
-
A Steady Hand in Saving Vision
Research NewsSubretinal injection is the most common form of delivery for gene therapies currently in clinical trials.
-
Fighting Blindness Gets Sheepish
Research NewsResearchers in Israel are developing a gene therapy for achromatopsia that may help both sheep and humans alike.
-
ARVO 2016: High-School Sophomore Finds Gene Mutation in Family with Choroideremia
Research NewsAditya A. Guru, 16, used whole exome sequencing (WES), an innovative genetic-screening technology, to find the mutation.
-
ARVO 2016: Emerging Drug Targets Toxic Build-Up in Stargardt Disease
Research NewsIn August 2015, the biotech company Alkeus launched a multi-center TEASE Phase II clinical trial for the drug ALK-001.
-
ARVO 2016: What Does It Take to Develop a Stem-Cell Therapy for the Retina?
Research NewsThere are innumerable considerations for researchers developing therapies.
-
ARVO 2016: ProgSTAR, FFB-CRI's Stargardt Disease Patient Study, Highlighted
Research NewsWhen the study and the reports are completed, the ProgSTAR database will be made available to researchers and companies developing therapies.
-
Beacon Stories
An interview with Louis Posen, record label founder and retinitis pigmentosa patient.
-
Beacon Stories
People with retinal disease describe their experiences “not looking blind.”
-
Changing Someone’s Life: A New Video Emphasizes the Need to Support FFB’s Mission
Beacon StoriesAllison Corona is one of 40 people with Leber congenital amaurosis who’ve benefitted from a gene therapy clinical trial.
